Literature DB >> 16737812

Quality of life and persisting symptoms after oesophageal cancer surgery.

Pernilla Viklund1, Yvonne Wengström, Ioannis Rouvelas, Mats Lindblad, Jesper Lagergren.   

Abstract

To assess quality of life (QoL) and symptoms after oesophageal cancer surgery, a prospective nationwide population-based study was conducted in 2001-2005, including most surgically treated oesophageal cancer patients in Sweden. Six months postoperatively patients responded to an EORTC quality of life core questionnaire (QLQ C-30) with an oesophageal-specific module (OES-18). Mean scores were calculated. Mann-Whitney test was used for group comparisons. Among 282 patients, QoL was considerably reduced compared to a reference general population (P<0.001), and functioning scales were similarly negatively affected; particularly role (P<0.001) and social (P<0.001) functions. Younger patients scored worse than older. No gender differences were found. Dominating general symptoms included fatigue, appetite loss, diarrhoea, and dyspnoea, each significantly more pronounced than the general population (P<0.001). Eating problems, cough, reflux, and oesophageal pain were common oesophageal-specific symptoms. Thus, patients who undergo oesophageal cancer resection suffer greatly from reduced QoL and several general and oesophageal-specific symptoms six months postoperatively.

Entities:  

Mesh:

Year:  2006        PMID: 16737812     DOI: 10.1016/j.ejca.2006.02.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

1.  Diagnosis and management of Barrett's esophagus for the endoscopist.

Authors:  Sagar S Garud; Steven Keilin; Qiang Cai; Field F Willingham
Journal:  Therap Adv Gastroenterol       Date:  2010-07       Impact factor: 4.409

2.  Functional and radiological evaluation of free jejunal transplant reconstructions after radical resection of hypopharyngeal or proximal esophageal cancer.

Authors:  H Bergquist; M Andersson; H Ejnell; M Hellström; L Lundell; M Ruth
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.352

3.  Long-term quality of life after Ivor Lewis esophagectomy for esophageal cancer.

Authors:  Silvio Däster; Savas D Soysal; Lea Stoll; Ralph Peterli; Markus von Flüe; Christoph Ackermann
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

4.  Impact of the Level of Anastomosis on Reflux Esophagitis Following Esophagectomy with Gastric Tube Reconstruction.

Authors:  Makoto Sakai; Makoto Sohda; Tatsuya Miyazaki; Tomonori Yoshida; Yuji Kumakura; Hiroaki Honjo; Keigo Hara; Takehiko Yokobori; Hiroyuki Kuwano
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

5.  Role of dietitian support in improving weight loss and nutrition impact symptoms after oesophageal cancer surgery.

Authors:  Poorna Anandavadivelan; Anna Wikman; Kalle Mälberg; Helen Rosenlund; Asif Johar; Pernilla Lagergren
Journal:  Eur J Clin Nutr       Date:  2021-01-14       Impact factor: 4.016

Review 6.  Endoscopic Treatment of Early-Stage Esophageal Cancer.

Authors:  Mariam Naveed; Nisa Kubiliun
Journal:  Curr Oncol Rep       Date:  2018-07-30       Impact factor: 5.075

Review 7.  Quality of life assessment in esophagectomy patients.

Authors:  Alla Alghamedi; Gordon Buduhan; Lawrence Tan; Sadeesh Kumar Srinathan; Joanne Sulman; Gail Darling; Biniam Kidane
Journal:  Ann Transl Med       Date:  2018-02

8.  Struggling with food and eating--life after major upper gastrointestinal surgery.

Authors:  Sharon Carey; Rachel Laws; Suzie Ferrie; Jane Young; Margaret Allman-Farinelli
Journal:  Support Care Cancer       Date:  2013-05-29       Impact factor: 3.603

9.  Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer.

Authors:  Yu-Ling Chang; Yun-Fang Tsai; Yin-Kai Chao; Meng-Yu Wu
Journal:  Qual Life Res       Date:  2015-08-04       Impact factor: 4.147

10.  Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.

Authors:  E M L Verschuur; E W Steyerberg; H W Tilanus; S Polinder; M-L Essink-Bot; K T C Tran; A van der Gaast; L P S Stassen; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.